Last reviewed · How we verify

NCT03046277

Short- and Long-Term Renal Outcomes Following Lung Transplantation

Completed Last updated 5 February 2020
What this trial tests

trial testing No intervention in Lung Transplantation in 120 participants. Completed in 24 August 2019.

Timeline
22 March 2017
Primary endpoint
24 August 2019
24 August 2019

Quick facts

Lead sponsorUniversity of Giessen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date22 March 2017
Primary completion24 August 2019
Estimated completion24 August 2019
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Giessen

Who can join

18 and older, any sex, with Lung Transplantation or Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of acute kidney injury, renal recovery and development of chronic kidney disease in patients undergoing lung transplantation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients.
    Kuhnert S, Sommerlad J, Gall H, Weder MM, et al · · 2024 · cited 1× · PMID 39282762 · DOI 10.1111/ctr.15457

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Lung Transplantation

Currently open trials in the same condition.

Other University of Giessen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03046277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing